Funding Briefs

The Deafness Research Foundation has pared down the size of its 1990 grant application form to a sleek six pages in an attempt to stem the paper tide that was flooding its review board. “We were getting applications 40, 50 pages long,” says a staffer. “It was ridiculous.” Beginning with this year’s cycle (deadline: July 15), applications received on other forms will be rejected. The New York-based public charity, started 30 years ago by a grateful Collette Ramsey

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Deafness Research Foundation has pared down the size of its 1990 grant application form to a sleek six pages in an attempt to stem the paper tide that was flooding its review board. “We were getting applications 40, 50 pages long,” says a staffer. “It was ridiculous.” Beginning with this year’s cycle (deadline: July 15), applications received on other forms will be rejected.

The New York-based public charity, started 30 years ago by a grateful Collette Ramsey, whose hearing was restored after surgery, raises in excess of $1 million each year to award to scientists working in ear research. The foundation prefers to give small, $15,000 “seed” grants, with which new investigators can attract additional funds.

Next year, the foundation anticipates increases in both the total number of grant dollars (up to $2 million) and the number of grants awarded through its Research Grant Program into Hearing Loss and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies